11:13 AM EDT, 10/11/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were moving higher late Friday morning, rising 0.55% to 1,424.23 on the S&P Europe Select ADR Index, which is poised to end the week about 0.31% higher.

From continental Europe, the gainers were led by biopharmaceutical company Genfit ( GNFT ) and semiconductor company Sequans Communications ( SQNS ) , which advanced 10% and 2.5% respectively. They were followed by biopharmaceutical company Cellectis ( CLLS ) and pharmaceutical company Novo Nordisk ( NVO ) , which increased 2% and 1.8% respectively.

The decliners from continental Europe were led by medical device maker EDAP TMS ( EDAP ) and biopharmaceutical company Grifols ( GRFS ) , which fell 2.5% and 1.6% respectively. They were followed by biotech firm Evaxion Biotech ( EVAX ) and telecommunications company Nokia ( NOK ) , which were down 1.1% and 0.6% respectively.

From the UK and Ireland, the gainers were led by biotech firm Trinity Biotech ( TRIB ) and biopharmaceutical company Bicycle Therapeutics ( BCYC ) , which climbed 9.9% and 3.5% respectively. They were followed by software firm Endava ( DAVA ) and biotech firm Autolus Therapeutics ( AUTL ) , which rose 2.8% and 1.6% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Akari Therapeutics ( AKTX ) and insurance company Prudential (PUK), which lost 8.4% and 1.3% respectively. They were followed by telecommunications operator Vodafone Group ( VOD ) and pharmaceutical company GSK (GSK), which were off 0.9% each.